Abstract
Introduction
system, which has a hierarchic, multi-oscillator structure. The master clock is located in the hypothalamic time PCR were as follows: 95°C for 15 min followed by 45 cycles of 10 s at 94°C, 20 s at 60°C, and 30 s at 125 72°C.
127
Tissue preparation for organotypic culture of nasal mucosa D-luciferin potassium salt (Dojindo).
138

Real-time bioluminescence recording and analysis of circadian rhythms
139
Bioluminescence emitted from the cultured tissue was measured for 1 min at 10-min intervals using 140 a photomultiplier tube (LumiCycle; Actimetrics) as previously described (22) . Measurement continued for at 141 least 5 consecutive days. The recorded data were detrended using a 24-hour running average subtraction 142 method and further smoothed using a five-point moving average technique (23). Using a detrended circadian 143 rhythm that intersected the x-axis, the midpoint of two intersecting phases in a circadian cycle on the first 144 culture day was defined as the first peak phase. The amplitude (peak-trough difference) of the circadian 145 rhythm was standardized by dividing the amplitude by the peak value because the amplitude and peak value 146 showed a strong positive correlation (r = 0.997). The circadian period was calculated from a regression line 147 fitted to the first to fourth peak phases.
Thirteen microliters of DEX (final concentration: 10 −7 M; Sigma-Aldrich) or vehicle was added to 151 the culture medium at one of the following four phases on the fifth culture day: the circadian peak; the 152 following circadian trough; the middle points between the peak phase and trough phases before and after the 153 peak. After a DEX challenge, bioluminescence was recorded continuously for at least 10 cycles. The amount
154
of phase shift was calculated on the fifth culture day from the phase difference between the two regression 155 lines fitted to the four consecutive circadian peaks before and after the DEX challenge, respectively. The effects of a lower dose of DEX (final concentration: 10 −8 M) were also examined at the phases at which 10 −7
157
M DEX caused maximum phase-delay and -advance in PER2::LUC rhythm.
159
PRC construction: in vivo effects of DEX
160
To examine the effects of DEX in vivo, either DEX (300 μl/ml in PBS) or PBS was 161 intraperitoneally injected (2 mg/kg) at one of the four circadian phases (ZT0, ZT6, ZT12, or ZT18). Mice
162
were sacrificed at ZT9-10 after injection (on the same day for ZT0 and ZT6 and on the following day for
163
ZT12 and ZT18), and the nasal mucosa was cultured as described earlier. 
181
Localization of PER2-positive cells and day-night variation of gene expression in the nasal mucosa
182
Immunohistochemical examination revealed PER2-positive cells in both the respiratory and 183 olfactory epithelia of the nasal mucosa ( Figure 1 ). In both epithelia, PER2 was faintly expressed in epithelial clock gene expression in the respiratory epithelium of the nasal mucosa, the site most affected by AR (24).
188
mRNA expression in the nasal mucosa
189
In the nasal mucosa, significant circadian variations in the levels of mPer1 and mPer2 mRNA were
190
detected by quantitative RT-PCR (mPer1, p < 0.05, mPer2, p < 0.01; n = 6-8; Figure 2A and B).
the late light period of a light-dark (LD) cycle, and the trough occurred in the late dark period. The amplitude 193 of circadian mPer1 rhythm was not as high as that of mPer2 rhythm, suggesting that its circadian peak 194 occurred between ZT8 and ZT12. Thus, the circadian rhythm of mPer1 mRNA was slightly phase-advanced 195 relative to that of mPer2 mRNA in the nasal mucosa, similar to other areas of the body (25). In contrast, there
196
were no significant circadian changes in the mRNA level of glucocorticoid receptor (GR; n = 6-8; Figure 2C ).
198
Circadian PER2::LUC rhythm in cultured nasal mucosa
199
Cultured nasal mucosa exhibited a robust circadian rhythm in PER2::LUC expression and peaking
200
at the phase corresponding to the early dark period (ZT14.2 ± 0.3) on the first day of culture. We standardized the circadian amplitude in individuals by dividing it by the peak level. The standardized amplitude was 1.7 ± 202 0.02 on the first culture day, and the circadian period, calculated using four consecutive peak phases, was 22.7
203
± 0.1 h. The PER2::LUC rhythm gradually damped over the course of culture at a damping rate of 0.1 ± 0.01,
204
where damping rate was defined as a ratio of the circadian amplitude on the fourth culture day to that on the 205 first culture day (n = 15, mean ± SEM; Figure 3 ).
207
Phase-dependent phase shifts in PER2 rhythm caused by dexamethasone in the nasal mucosa ex vivo
208
(ex vivo PRC)
209
In the ex vivo experiment, the time of circadian peak of PER2::LUC rhythm in culture was defined 
241
The effects of endogenous glucocorticoids on the peripheral circadian clock in nasal mucosa were 
248
Effects of DEX on circadian properties other than phase
249
A DEX challenge dramatically restored the dampened circadian PER2::LUC rhythm in the ex vivo 250 experiment ( Figure 6A ). The recovery rate of the circadian amplitude caused by DEX was 3.3 ± 0.4 (n = 17),
251
where the recovery rate was defined as the ratio of the circadian amplitude on the sixth day of culture (a day after the DEX challenge) to that on the fourth day of culture (a day before the DEX challenge). Such recovery 253 of the circadian amplitude was not observed in the control group (recovery rate: 0.2 ± 0.03; n = 16). There was 254 no significant phase-dependency in recovery rate (n = 4-5; Figure 6B ) following the administration of either
255
DEX or vehicle alone. On the other hand, the amplitude damping rate of consecutive circadian rhythms did 256 not differ significantly between before (day2/day1) and after (day7/day6) DEX challenge (before, 0.6 ± 0.03; 257 after, 0.5 ± 0.01, n=17).
259 260
Discussion
261
The mammalian circadian clock comprises the master clock in the SCN and peripheral clocks in a
262
variety of tissues (13 
313
To our surprise, ADX had little effect on the circadian parameters of PER2::LUC rhythms in the 314 cultured nasal mucosa. The effects of ADX on circadian rhythms are reported to differ among various tissues 315 and among genes. ADX has no effect on peripheral clocks in the pituitary gland, lung, and some extra SCN 
322
In the present study, we found that the expression of GR mRNA in the nasal mucosa remained 323 unchanged throughout the day (Figure 2) . The phase-dependent phase-shifting effect of DEX can be attributed 
331
In the present study, the circadian amplitude increased after the DEX challenge, but the increment 332 of amplitude was the same throughout the circadian day. The mechanism of amplification caused by DEX is 333 unknown, but the amplification seems to subside within one cycle because the amplitude damping rate did not 334 differ before and after DEX challenge. Furthermore, the amplification is unlikely to be mediated though the 335 circadian clock, since the increase in rhythm amplitude was not correlated with the extent of phase-shift. A are metabolized rapidly, and no significant adverse effect on the HPA axis has been reported (49). From the 341 viewpoint of circadian physiology, the best time for INS would be from ZT0-6, the early-to-mid light phase, 342 when no phase shift is caused by DEX. In the case of diurnal humans, this corresponds to the early evening.
343
This is consistent with findings that aerosol corticosteroid administered at this time was most effective for the 
348
to an undesired direction may obscure the optimal timing of following treatments.
349
In conclusion, our results provide evidence of a mechanism of resetting the circadian clock in the 
